Refractory Bullous Pemphigoid Improved by Discontinuation of Phenytoin as an CYP3A4 Inducer

Abstract is missing (Short communication)

Saved in:
Bibliographic Details
Published inActa dermato-venereologica Vol. 100; no. 8; pp. adv00108 - 2
Main Authors Yokoyama, Rei, Hayashi, Ryota, Umemori, Yukie, Arimatsu, Ami, Yuki, Akihiko, Abe, Riichiro
Format Journal Article
LanguageEnglish
Published Sweden Medical Journals Sweden 01.04.2020
Subjects
Aged
Anti-Inflammatory Agents - therapeutic use
Anticonvulsants - therapeutic use
bullous pemphigoid
Cerebral Palsy - complications
Cerebral Palsy - drug therapy
corticosteroid
cyp3a4
Cytochrome P-450 CYP3A Inducers - therapeutic use
Drug Substitution
Epilepsy - complications
Epilepsy - drug therapy
Humans
Levetiracetam - therapeutic use
Male
Pemphigoid, Bullous - complications
Pemphigoid, Bullous - therapy
phenytoin
Phenytoin - therapeutic use
Prednisolone - antagonists & inhibitors
Prednisolone - therapeutic use
corticosteroid
bullous pemphigoid
CYP3A4
phenytoin
Online AccessGet full text

Cover

More Information
Summary:Abstract is missing (Short communication)
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1651-2057
0001-5555
1651-2057
DOI:10.2340/00015555-3472